Health Canada Authorizes the Covclear COVID-19 Rapid Antigen Test for Self-testing
Empowered Diagnostics LLC, a U.S.-based manufacturer of innovative rapid diagnostic tests, announced that it has received Health Canada authorization for its CovClear COVID-19 Rapid Antigen Test in Canada for at-home, self-testing use.
This test has been authorized under Health Canada’s Interim Order 330172. According to the Health Canada website the CovClear test has a nasal sensitivity of 96% for symptomatic and asymptomatic testing.
CovClear is a lateral flow test that can detect active COVID-19 infection among symptomatic or asymptomatic individuals. The lower nasal swab test produces highly accurate results within minutes and is quick and easy to use. It has been researched, developed and manufactured in the United States.
Although it is unknown at this time when the test will be available for sale in Canada, the recent flurry of authorized self-testing antigen rapid tests surely shows the direction that Health Canada is moving.